CION Ameerpet
Hodgkin lymphoma has an early peak in the late teens, 20s and early 30s — so a diagnosis when you are young is not unusual. It is also one of the most treatable cancers. This guide explains the first signs, how it is diagnosed and treated, fertility, and the outlook.
Hodgkin lymphoma is a cancer of the lymphatic system — the network of nodes and vessels that is part of your immune system. What sets it apart from most cancers is its age pattern: it has an early peak in people aged roughly 15 to 35, then a second peak later in life. That is why Hodgkins in your 20s is one of the most familiar forms of lymphoma a young, otherwise healthy person can face — and it is important to know from the outset that it is also one of the most curable cancers.
For a young adult, a lymphoma diagnosis lands at a time full of study, early careers, relationships and family plans. Care therefore has to do two things at once: treat the disease effectively, and protect the decades of life ahead — including fertility and long-term health. This page is written for exactly that situation. For the fundamentals of the disease itself, see Hodgkin lymphoma — what it is.
Below we cover why it affects young adults, the first signs to watch for, how it is diagnosed and staged, the treatment building blocks CION delivers, the fertility conversation that should happen up front, and the outlook. If you already have a diagnosis and want a plan, our Lymphoma Treatment in Hyderabad page and best lymphoma doctors in Hyderabad are the next step.
Hodgkin lymphoma is one of the most common cancers of young adulthood — it has a well-recognised age peak between roughly the ages of 15 and 35, before a second peak after age 55. It is also one of the most treatable of all cancers, with high published long-term cure rates, particularly for young people diagnosed at an early stage. (Source: age-distribution and survival data as summarised in NCCN and ESMO Hodgkin lymphoma guidelines.)
Most swollen lymph nodes in young people are harmless reactions to infection. The pattern below is what warrants a check — especially if it persists beyond three to four weeks.
The classic first sign is a firm, painless swelling of a lymph node — most often in the neck, above the collarbone, or in the armpit — that does not settle over a few weeks. It usually does not hurt, which is part of why it can be missed.
Unexplained fevers, drenching night sweats and unintentional weight loss are known together as B symptoms. In a young adult, these — especially alongside a swollen node — should prompt a medical review rather than watchful waiting.
Persistent tiredness that is out of proportion to your activity, or generalised itching of the skin without a rash, can also occur. Occasionally a node becomes uncomfortable after drinking alcohol — an unusual but recognised clue.
See a doctor if a node is firm, painless and persists beyond three to four weeks, or if you have B symptoms. Learn the full pattern on our Hodgkin lymphoma symptoms page, or book a free consultation.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Just diagnosed, want to understand your stage and subtype, or need a second opinion before treatment? CION's lymphoma team supports young adults through diagnosis, treatment and survivorship.
Getting the diagnosis right — and knowing how far the disease has spread — sets up the whole plan. CION delivers biopsy, imaging and bone-marrow assessment directly, and every case is reviewed at a multidisciplinary tumour board.
Diagnosis requires a biopsy of an affected lymph node — ideally removing the whole node so the pathologist can see its architecture. The hallmark of Hodgkin lymphoma is the Reed–Sternberg cell, and markers such as CD30 and CD15 are tested to confirm the type. These molecular markers are testing concepts that help pin down the exact subtype — for example classical Hodgkin lymphoma versus the less common nodular lymphocyte-predominant form.
A PET-CT scan maps where the lymphoma is active throughout the body and sets the stage (from I to IV). Blood tests and, where indicated, a bone-marrow assessment complete the picture. Staging matters a great deal in a young adult, because early-stage disease is often treated with a shorter, less intensive plan than advanced-stage disease.
Most young adults have classical Hodgkin lymphoma, and the nodular sclerosis subtype is especially common in this age group. A smaller number have nodular lymphocyte-predominant Hodgkin lymphoma, which behaves differently. Identifying the exact subtype is part of what the biopsy and immunohistochemistry achieve.
Hodgkin lymphoma responds well to treatment, and the plan is tailored to your stage, subtype and general health. We describe treatments here by type and mechanism; specific drug regimens are decided at consultation and covered on our Lymphoma Treatment in Hyderabad page.
The backbone of treatment for most young adults is combination chemotherapy, given in cycles over a number of months. The exact combination and number of cycles depend on the stage and response, and are decided in line with NCCN and ESMO guidance. CION's medical oncology team delivers chemotherapy directly, with proactive management of side effects such as nausea and fatigue.
For some early-stage patients, a short course of radiation therapy to the affected area is added after chemotherapy. CION delivers precision radiation (IMRT/IGRT) directly, shaping the dose to reduce exposure to healthy tissue — an important consideration for a young person who will live for decades afterwards.
For selected or relapsed disease, modern antibody-based therapy (for example agents directed at the CD30 marker on Hodgkin cells) and immunotherapy that re-activates the immune system are part of the toolkit, and are delivered directly by our team where appropriate.
If the disease returns, higher-dose therapy supported by a stem-cell transplant may be considered. CION coordinates this through accredited partner transplant facilities rather than delivering it in-house, so you get seamless referral and shared follow-up. More on options at relapsed Hodgkin lymphoma.
Both NCCN and ESMO guidelines advise that a discussion about fertility preservation should happen before the first cycle of lymphoma treatment — because some regimens can affect future fertility and options such as sperm banking or egg/embryo freezing work best when arranged up front. In a young adult, this conversation is a standard part of good care, not an optional extra. (Source: fertility-preservation recommendations in NCCN and ESMO Hodgkin lymphoma guidelines.)
Because young adult lymphoma is so treatable, the questions that matter most are often about the years afterwards. Two areas deserve attention from day one:
If you are weighing up these decisions, talk to a CION specialist before treatment begins — early planning gives you the most options.
The outlook for Hodgkin lymphoma in young adults is generally very encouraging. In published series, overall long-term survival is roughly 80–90%, and young, otherwise healthy people diagnosed at an early stage often sit at the higher end (figures per NCCN and ESMO data). For context, aggressive non-Hodgkin subtypes such as DLBCL have published survival closer to 60–70%. These are population figures and vary by individual — your stage, subtype, general health and how the disease responds all matter.
What this means in practice is that for most young adults, treatment is given with the clear goal of long-term remission and a return to normal life. A deeper discussion of cure rates, remission and follow-up is on our Hodgkin lymphoma survival & cure rates page.
CION offers a dedicated, free written second-opinion service — you deserve a plan built around healing and your future, with transparent costs explained up front. Request your free second opinion or call 18002028726. You can also review the best lymphoma hospital in Hyderabad for how our care is set up.
Get a free written second opinion from CION's lymphoma tumour board — especially valuable for young adults who want fertility and long-term health considered before treatment starts.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Hodgkin lymphoma has an unusual age pattern: it peaks first in people in their late teens, 20s and early 30s, and again after about 55. So a diagnosis of Hodgkin lymphoma in your 20s is not unusual — young adults are one of the groups it most affects. The exact reason for this early peak is not fully understood, but it is linked in part to the immune system and, in some cases, to a past Epstein–Barr virus infection. The good news is that Hodgkin lymphoma in young, otherwise healthy adults is one of the most treatable cancers, with high published cure rates. Care at CION is coordinated so that a young adult diagnosis is handled with both urgency and a long-term view of survivorship.
The most common first sign is a painless, firm swelling of a lymph node — usually in the neck, above the collarbone, or in the armpit — that does not settle over a few weeks. Some young adults also notice so-called "B symptoms": unexplained fevers, drenching night sweats, or losing weight without trying. Persistent tiredness, itching all over the skin, or (less often) discomfort in a lymph node after drinking alcohol can also occur. These symptoms have many ordinary causes, so most swollen nodes are not lymphoma — but a firm, painless node that persists beyond three to four weeks should be checked. You can read more about the pattern of Hodgkin lymphoma symptoms on our dedicated page.
This is one of the most important questions for young adults, and it deserves a clear answer before treatment starts. Some lymphoma treatments — certain chemotherapy combinations and radiation to the pelvis — can affect fertility, while others carry a much lower risk. Because Hodgkin lymphoma is so treatable, planning for life after treatment matters. National and European guidelines (NCCN and ESMO) advise discussing fertility preservation before the first cycle. At CION we raise this early and coordinate options such as sperm banking or egg/embryo freezing through partner reproductive-medicine services. Please see our fertility preservation before lymphoma treatment page and raise it at your first consultation.
Many young adults are able to continue studying or working, at least part-time, through parts of their treatment — though this varies a lot with the regimen, how you tolerate it, and the intensity of your schedule. Treatment is often given in cycles over several months, with good and harder days within each cycle. Fatigue is the most common limiting symptom. Practical planning — spacing exams, arranging flexible hours, and managing side effects proactively — makes a real difference. Our team plans appointments around your commitments where possible and connects you with survivorship and supportive-care services. Talk to us about your situation so we can build a plan that fits your life, not just the calendar.
Diagnosis needs a biopsy of an affected lymph node — ideally removing the whole node — examined by a specialist pathologist who looks for the characteristic Reed–Sternberg cells and tests markers such as CD30 and CD15. A PET-CT scan then maps how far the disease has spread, which sets the stage. Blood tests complete the picture. From first appointment to a confirmed diagnosis and stage usually takes days to a couple of weeks, depending on how quickly the biopsy and scans are done. CION performs biopsy, bone-marrow assessment where needed, and imaging directly, and every case is reviewed at a tumour board before treatment is finalised.
The outlook is generally very good. In published series, Hodgkin lymphoma has an overall long-term survival of roughly 80–90%, and young, otherwise healthy adults — especially those diagnosed at an early stage — often sit at the higher end of that range (figures per NCCN and ESMO data). By contrast, aggressive non-Hodgkin subtypes such as DLBCL have published survival closer to 60–70%. These figures vary by individual, stage, subtype and response to treatment, so they are a guide, not a promise. Because so many young survivors live for decades, modern care also focuses on minimising the long-term effects of treatment. For a full discussion of prognosis, see our Hodgkin lymphoma survival & cure rates page.
Even when Hodgkin lymphoma returns after first-line treatment, there are effective further options, and many young adults still achieve long-term remission. Relapsed disease is usually treated with a different chemotherapy approach, sometimes followed by higher-dose therapy supported by a stem-cell transplant — a step CION coordinates through accredited partner transplant facilities rather than delivering in-house. Newer antibody-based and immunotherapy options are also part of the modern relapse toolkit and are delivered directly by our medical oncology team where appropriate. Every relapse is re-staged and reviewed by the tumour board. You can read more on our relapsed Hodgkin lymphoma page, or book a free consultation to discuss your specific situation.
Browse our complete guide to lymphoma — symptoms, diagnosis, Hodgkin and non-Hodgkin subtypes, treatment, genetics, prognosis, survivorship and cost. Tap any topic to read more.